The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say ...
3h
Asian News International on MSNKauvery Hospital Achieves a Remarkable Milestone - 500+ Cardiothoracic Surgeries in Just 18 Months!From high-risk bypass surgeries and valve replacements to minimally invasive procedures, Kauvery Hospital's expert cardiothoracic team has been at the forefront of innovation, ensuring faster recovery ...
Chief Dr. Shalimar S. Rakiin and PhilHealth-BARMM Regional Vice President Datu Masiding M. Alonto Jr. sign a memorandum of ...
Kauvery Hospital in Salem celebrates an extraordinary achievement, completing over 500 cardiothoracic surgeries within 18 ...
3d
GlobalData on MSNCapstan Medical’s robotic platform used for first mitral valve replacementsBuoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...
EFFECTIVE March 1, 2025, the Philippine Health Insurance Corp. (PhilHealth) is expanding its Z Benefits Package for open heart surgeries and introducing a new package for heart valve repair and ...
Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...
Procedural planning and attention to detail can help, but heart teams should be realistic about what lies ahead, experts say.
[1] Nonrandomized studies first suggested that mechanical reperfusion of occluded coronary arteries by percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery ...
3d
Hosted on MSNREVB Starts 2025 With Bright Future AheadREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of ...
The Company now expects to report fourth quarter and full year 2024 financial results after the market close on Tuesday, ...
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $10.4 million during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results